Kiromic Biopharma Competitors and Similar CompaniesClear all
Kiromic Biopharma's competitors and similar companies include Xilio Therapeutics, RAPT Therapeutics, Alligator Bioscience and Rakuten Medical.
 Kiromic Biopharma Kiromic BioPharma (formerly known as Kiromic) is a target discovery and gene editing company focusing on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors. |  Xilio Therapeutics Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics. |  RAPT Therapeutics RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents. |  Rakuten Medical Rakuten Medical (formerly Rakuten Aspyrian) is a clinical stage biotechnology company developing tumor-targeted precision therapies. | ||
Founding Date | Founding Date 2012 | Founding Date 2015 | Founding Date 2015 | Founding Date 2001 | Founding Date 2013 |
Type | Type Public | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Houston, US HQ | Locations Waltham, US HQ | Locations South San Francisco, US HQ | Locations Lund, SE HQ | Locations San Diego, US HQ Setagaya City, JP Amsterdam, NL Ecublens, CH Taipei, TW Taipei, TW San Mateo, US |
Employees | Employees 4426% increase | Employees 69 | Employees 64 | Employees 1555% decrease | Employees 1241% increase |
Valuation ($) | Valuation ($) 1.8 m | Valuation ($) 43.5 m | Valuation ($) 69.8 m | Valuation ($) 59 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $43.8m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) kr514k (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($26.9m) (FY, 2024) | Net income ($35m) (FY, 2025) | Net income ($129.9m) (FY, 2024) | Net income (kr51.4m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 135k | Total funding raised $ 233m | Total funding raised $ 176m | Total funding raised N/A | Total funding raised $ 451.9m |
For sources of this data, please see the company profile
View Company Profiles
Xilio Therapeutics
HQ
Waltham, US
Employees
69
Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics.
View companyRAPT Therapeutics
HQ
South San Francisco, US
Employees
64
RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents.
View company
Alligator Bioscience
HQ
Lund, SE
Employees
15
Alligator develops antibody-based pharmaceuticals for cancer treatment.
View companyRakuten Medical
HQ
San Diego, US
Employees
124↑ 1% increase
Rakuten Medical (formerly Rakuten Aspyrian) is a clinical stage biotechnology company developing tumor-targeted precision therapies.
View company